missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Tocris Bioscience™ RECTAS
IKBKAP pre-mRNA splicing modulator
202.00 € - 774.00 €
Specifications
| Chemical Name or Material | 2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine |
|---|---|
| CAS | 101862-47-9 |
| Target | DNA, RNA and Protein Synthesis Compounds |
| Molecular Formula | C10H8ClN5O |
| Purity | 0.98 |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|
18708626
|
Tocris Bioscience™
7679/10 |
10 mg |
202.00 €
10mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
|
18707026
|
Tocris Bioscience™
7679/50 |
50 mg |
774.00 €
50mg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
RECTAS (rectifier of aberrant splicing) is a pre-mRNA splicing modulator of the IKBKAP (inhibitor of κ light polypeptide gene enhancer in B-cells, kinase complex associated protein) gene. It corrects aberrant IKBKAP splicing in vitro in cellular models of familial dysautonomia and in vivo in transgenic mice. In combination with Phenylbutyric acid (Cat. No. 2682), RECTAS rescues PARK7 aberrant splicing and neuronal cell loss in a midbrain organoid model of familial Parkinson's disease. Orally bioavailable and brain penetrant.Specifications
| 2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine | |
| DNA, RNA and Protein Synthesis Compounds | |
| 0.98 |
| 101862-47-9 | |
| C10H8ClN5O |
Safety and Handling
Recommended Storage : Store at -20°C
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title